IP Library Granted Patent US 7,074,895
Granted Patent B2
US 7,074,895 · App. 09/802,472 · Granted Jul 11, 2006

Sequences characteristic of hypoxia-regulated gene transcription

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,895
App. No.
09/802,472
Granted
Jul 11, 2006
Kind
B2
Abstract

There are provided polynucleotides which are modulated by hypoxic conditions. The disclosure includes such genes and proteins as well as analogs, salts and functional derivatives of such proteins, and DNA encoding such analogs, and methods of use. Methods for treating the effects of stroke, hypoxia and/or ischemia by regulating such genes or proteins are also disclosed. The presence of hypoxia or a hypoxia-associated pathology may be diagnosed by screening for the presence of at least one polynucleotide having the nucleic acid sequence according to the present invention. Methods of regulating hypoxia associated pathologies are also provided.

Claims (1)

1. An isolated polypeptide comprising SEQ ID NO:4.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2008
From: KALINSKI, HAGAR
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021640/0280 →
CHANGE OF NAME Recorded Oct 7, 2008
From: QUARK BIOTECH, INC.
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021658/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2004
From: REGEV, AVIV
To: QUARK BIOTECH, INC.
Reel/Frame 014816/0386 →